LPCN
Lipocine Inc
NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY
$2.33
+0.00% today
Updated 2026-05-01
Market cap
$19.02M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.77
Dividend yield
—
52W range
$2 – $12
Volume
0.5M
Lipocine Inc (LPCN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-219.60%
ROE
-54.30%
ROA
-32.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $3.09M | $-5162.00 | — | -0.17% | -0.17% |
| 2012 | $7.71M | $-76654.00 | 50.86% | -0.99% | -0.99% |
| 2013 | $0.00 | $-10.59M | — | — | — |
| 2014 | $0.00 | $-20.37M | — | — | — |
| 2015 | $0.00 | $-18.21M | — | — | — |
| 2016 | $0.00 | $-18.97M | — | — | — |
| 2017 | $0.00 | $-20.98M | — | — | — |
| 2018 | $428031.00 | $-11.66M | 100.00% | -2,646.03% | -2,724.11% |
| 2019 | $164990.00 | $-13.01M | -4,426.46% | -7,818.83% | -7,883.72% |
| 2020 | $0.00 | $-20.96M | — | — | — |
| 2021 | $16.14M | $-634399.00 | 52.51% | 19.49% | -3.93% |
| 2022 | $500000.00 | $-10.76M | -1,611.38% | -2,423.88% | -2,151.73% |
| 2023 | $-2.85M | $-16.35M | 456.92% | 628.98% | 573.59% |
| 2024 | $11.20M | $8352.00 | 100.00% | -10.31% | 0.07% |
| 2025 | $1.98M | $-9.63M | -334.26% | -524.69% | -487.06% |